Public Release Summary on the evaluation of the new active rescalure in the product CheckMate CRS

This consultation closed on 14 June 2022.
Consultation period: 
17 May 2022 to 14 June 2022

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for registration of the product Checkmate CRS, a Slow Release Generator (SR) formulation containing 716 g/L (70 mg/dispenser) of the new active constituent, rescalure. The product is intended for the use in mating disruption of Aonidiella aurantii Maskell (California red scale) in citrus and any other crops where this species may be a pest. 

We invite comment from 17 May 2022 to 14 June 2022 on whether approval of the active constituent and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds, including:

  • occupational health and safety 
  • public health
  • chemistry and manufacture
  • residues in food
  • efficacy and target crop safety.

Download the Public Release Summary on the evaluation of Checkmate CRS.

For more information see page 17, APVMA Gazette No. 10, May 2022.

Please note: submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential, or if the APVMA chooses at its discretion not to publish any submissions received (refer to the public consultation coversheet).

Please lodge your submission using the public consultation coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:

Post:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Telephone: +61 2 6770 2300
Email: enquiries@apvma.gov.au

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.